Kadcyla 100mg Injection is a targeted therapy for HER2-positive breast cancer, combining Trastuzumab and emtansine. Trastuzumab targets HER2 receptors on cancer cells, while emtansine delivers chemotherapy directly to the tumor. Administered intravenously, Kadcyla helps slow or halt tumor growth. Regular monitoring for side effects like heart or liver issues is necessary.